HealthTree Logo
search more_vert
close
person Sign In / Create Account
Unveiling the Potential of CAR-T Therapy For Treating Relapsed/Refractory Myeloma in the Black Myeloma Community
Unveiling the Potential of CAR-T Therapy For Treating Relapsed/Refractory Myeloma in the Black Myeloma Community image
Black Myeloma Health Community
event Mar 28, 2024 / 02:00PM - 03:00PM EDT

Event Description

Join us for an insightful event that delves into the revolutionary advancements in disease treatment through CAR-T therapy. This groundbreaking approach has transformed the landscape of medical care, offering hope where previously there was none. However, despite its remarkable efficacy, not all patients are reaping the benefits of this life-saving treatment option.

At this event, myeloma expert Dr. Sikander Ailawadhi from Mayo Clinic Jacksonville will explore the barriers hindering patient access to CAR-T therapy. From logistical challenges such as limited availability and high costs to the emotional burden of navigating through fear and uncertainty, many individuals are being left without the opportunity to explore this cutting-edge treatment.

We will address the disparities in access, discussing how socioeconomic factors, healthcare infrastructure, and disparities in information contribute to unequal distribution. Additionally, we will shed light on the reluctance of some patients to pursue CAR-T therapy due to concerns about the availability of caregivers during treatment and worries about the impact on their employment and financial stability.

Join us as we embark on a journey to empower patients and unlock the full potential of CAR-T therapy in disease treatment.

Schedule & Agenda

The panelist Valarie Traynham
Introductions
2:00 PM
Valarie Traynham

Valarie introduces the agenda of the event and our featured speaker Dr. Sikander Ailawadhi

The panelist Dr. Sikander Ailawadhi
Hope for MGUS/Smoldering Myeloma Patients
2:05 PM
Dr. Sikander Ailawadhi

Dr. Sikander Ailawadhi shares about barriers hindering patient access to CAR-T therapy.

person
Questions and Answers
2:35 PM
Audience

Type your questions in the chat and we will answer them! 

Speakers & Moderators

The panelist Valarie Traynham
Valarie Traynham

Valarie embarked on her myeloma journey back in 2015, and ever since she's been on a mission. As a resilient myeloma thriver, her passion lies in not just navigating her own path but also in illuminating the journey for others. With a steadfast commitment to understanding the intricacies of the disease, she champions education, shedding light on health inequities that often lurk in the shadows. Driven by a profound belief in fairness, Valarie tirelessly advocates for equitable access to top-tier healthcare, clinical trials, and tailored treatments. Her journey as a beacon of knowledge and support began when she assumed the role of a support group leader. Today, she continues to extend her hand as a myeloma coach, mentor angel, and the guiding force behind the Black Myeloma Health Community. Valarie's voice echoes far and wide as she fearlessly confronts the disparities faced by myeloma patients. Through collaborative efforts with healthcare providers, she strives to forge pathways to solutions, ensuring that every individual receives the care they deserve. Join Valarie on her journey of empowerment and advocacy as she lights the way toward a brighter, more equitable future in myeloma care.

Read Bio
The panelist Dr. Sikander Ailawadhi
Dr. Sikander Ailawadhi

Sikander Ailawadhi, MD, is a Professor of Medicine in the Division of Hematology/Oncology at the Mayo Clinic Florida located in Jacksonville, Florida. He is also the Lead for the International Cancer Center. Dr Ailawadhi's career focus includes the treatment of plasma cell disorders, multiple myeloma (MM), Waldenström's macroglobulinemia, and chronic lymphocytic leukemia (CLL). His research focuses on understanding the epidemiology and pathophysiology of these disorders; evaluating the benefit of various therapeutic strategies in different populations based on racial-ethnic and socioeconomic diversity; and developing novel therapeutics by means of conducting several regional and national clinical trials, such as clinical trials for novel drugs. Dr Ailawadhi has a special interest in understanding the disparities in care of cancer patients and their outcomes with a special focus on patients from different racial and ethnic backgrounds.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Sanofi
Pfizer
Regeneron
Adaptive
Bristol Myers Squibb

Follow Us

facebook instagram linkedin tiktok youtube